MiR-377 suppresses cell proliferation and metastasis in gastric cancer via repressing the expression of VEGFA

被引:4
作者
Wang, C. -Q. [1 ]
Chen, L. [2 ,3 ]
Dong, C. -L. [4 ]
Song, Y. [1 ]
Shen, Z. -P. [5 ]
Shen, W. -M. [1 ]
Wu, X. -D. [1 ]
机构
[1] Yancheng City 1 Peoples Hosp, Dept Gastroenterol, Yancheng, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 2, Dept Digest Endoscopy, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Affiliated Hosp 2, Med Ctr Digest Dis, Nanjing, Jiangsu, Peoples R China
[4] Yancheng City 1 Peoples Hosp, Dept Emergency, Yancheng, Peoples R China
[5] Yancheng City 1 Peoples Hosp, Dept Digest Endoscopy, Yancheng, Peoples R China
关键词
miR-377; Gastric cancer; Proliferation; Metastasis; VEGFA; TUMOR-SUPPRESSOR; DOWN-REGULATION; GROWTH; CARCINOMA; PROMOTES; INVASION; PATHWAY; ANGIOGENESIS; PATHOGENESIS; CONTRIBUTES;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: In recent years, microRNAs have been identified to participate in tumor genesis and progression of different tumors including gastric cancer. However, the role of miR-377 played in gastric cancer (GC), and its mechanisms have not been demonstrated. PATIENTS AND METHODS: We detected miR-377 expression level in 86 GC and adjacent normal tissue samples by quantitative reverse transcription PCR (qRT-PCR) as well as in GC cell lines. The relationship between miR-377 and clinical pathological features was analyzed. Using miR-377 mimics and inhibitors, we interfered with miR-377 level and employed several functional experiments to study the miR-377 effects on cell proliferation, migration, and invasion. Western blot assay and dual-luciferase assay were used to verify the target of miR-377. RESULTS: miR-377 expressed significantly lower in GC tissues and cell lines compared to normal tissues and GES-1 cells. Overexpression of miR-377 inhibited cell growth, migration and invasion, while downregulation miR-377 obviously promoted cell growth and metastasis. Furthermore, vascular endothelial growth factor A (VEGFA) was confirmed as a direct target of miR-377 and reversed the influence of mir-377 over-expression. CONCLUSIONS: miR-377 expressed lower in GC and suppressed cell proliferation, migration and invasion partly via repressing the VEGFA expression, which could provide a potential target for GC diagnosis and therapy.
引用
收藏
页码:5101 / 5111
页数:11
相关论文
共 35 条
[1]   Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues [J].
Bando, H ;
Brokelmann, M ;
Toi, M ;
Alitalo, K ;
Sleeman, JP ;
Sipos, B ;
Gröne, HJ ;
Weich, HA .
INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (02) :184-191
[2]  
CHEN G, 2015, PLOS ONE, V10
[3]   Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A [J].
Chen, Hongxia ;
Li, Lingmin ;
Wang, Shaojun ;
Lei, Yupeng ;
Ge, Qi ;
Lv, Nonghua ;
Zhou, Xiaodong ;
Chen, Changyan .
ONCOTARGET, 2014, 5 (23) :11873-11885
[4]   Global patterns of cardia and non-cardia gastric cancer incidence in 2012 [J].
Colquhoun, A. ;
Arnold, M. ;
Ferlay, J. ;
Goodman, K. J. ;
Forman, D. ;
Soerjomataram, I. .
GUT, 2015, 64 (12) :1881-U71
[5]   VEGF targets the tumour cell [J].
Goel, Hira Lal ;
Mercurio, Arthur M. .
NATURE REVIEWS CANCER, 2013, 13 (12) :871-882
[6]   VEGF-A splicing: the key to anti-angiogenic therapeutics? [J].
Harper, Steven J. ;
Bates, David O. .
NATURE REVIEWS CANCER, 2008, 8 (11) :880-887
[7]   Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer [J].
He, Chuan ;
Wang, Libo ;
Zhang, Jiantao ;
Xu, Hong .
MOLECULAR CANCER, 2017, 16
[8]   MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF [J].
Li, B. ;
Xu, W. W. ;
Han, L. ;
Chan, K. T. ;
Tsao, S. W. ;
Lee, N. P. Y. ;
Law, S. ;
Xu, L. Y. ;
Li, E. M. ;
Chan, K. W. ;
Qin, Y. R. ;
Guan, X. Y. ;
He, Q. Y. ;
Cheung, A. L. M. .
ONCOGENE, 2017, 36 (28) :3986-4000
[9]   miRNA423-5p regulates cell proliferation and invasion by targeting trefoil factor 1 in gastric cancer cells [J].
Liu, Jingjing ;
Wang, Xu ;
Yang, Xiaoning ;
Liu, Yunpeng ;
Shi, Ying ;
Ren, Jianlin ;
Guleng, Bayasi .
CANCER LETTERS, 2014, 347 (01) :98-104
[10]  
Liu XJ, 2016, EUR REV MED PHARMACO, V20, P3319